BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 2022;399:61-116. [PMID: 34863359 DOI: 10.1016/S0140-6736(21)01701-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Burra P, Ferrarese A. Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon. United European Gastroenterol J 2022. [PMID: 35474616 DOI: 10.1002/ueg2.12234] [Reference Citation Analysis]
2 Innes H, Morling JR, Buch S, Hamill V, Stickel F, Guha IN. Performance of routine risk scores for predicting cirrhosis-related morbidity in the community. J Hepatol 2022:S0168-8278(22)00129-5. [PMID: 35271950 DOI: 10.1016/j.jhep.2022.02.022] [Reference Citation Analysis]
3 Chapiro J. Translating artificial intelligence from code to bedside: The road towards AI-driven predictive biomarkers for immunotherapy of hepatocellular carcinoma. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.035] [Reference Citation Analysis]
4 Byrne CD, Newsome PN, Noureddin M. Why are there no Strategies for NAFLD? J Hepatol 2021:S0168-8278(21)02251-0. [PMID: 34933023 DOI: 10.1016/j.jhep.2021.12.009] [Reference Citation Analysis]
5 Macpherson I, Abeysekera KWM, Harris R, Mansour D, Mcpherson S, Rowe I, Rosenberg W, Dillon JF, Yeoman A. Identification of liver disease: why and how. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2021-101833] [Reference Citation Analysis]
6 Schomerus G, Leonhard A, Manthey J, Morris J, Neufeld M, Kilian C, Speerforck S, Winkler P, Corrigan PW. The stigma of alcohol-related liver disease and its impact on healthcare. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.04.026] [Reference Citation Analysis]
7 Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barré T, Casanova D, Carrieri P. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Harm Reduct J 2022;19:2. [PMID: 35012570 DOI: 10.1186/s12954-021-00587-0] [Reference Citation Analysis]
8 Donnelly MC, Stableforth W, Krag A, Reuben A. The negative bidirectional interaction between climate change and the prevalence and care of liver disease: A joint BSG, BASL, EASL, and AASLD commentary. J Hepatol 2022:S0168-8278(22)00118-0. [PMID: 35331574 DOI: 10.1016/j.jhep.2022.02.012] [Reference Citation Analysis]
9 Barré T, Di Marzo V, Marcellin F, Burra P, Carrieri P. Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock? Cannabis Cannabinoid Res 2022. [PMID: 35420457 DOI: 10.1089/can.2022.0014] [Reference Citation Analysis]
10 Labenz C, Arslanow A, Nguyen-Tat M, Nagel M, Wörns MA, Reichert MC, Heil FJ, Mainz D, Zimper G, Römer B, Binder H, Farin-Glattacker E, Fichtner U, Graf E, Stelzer D, Van Ewijk R, Ortner J, Velthuis L, Lammert F, Galle PR. Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL. J Hepatol 2022:S0168-8278(22)00244-6. [PMID: 35472313 DOI: 10.1016/j.jhep.2022.04.009] [Reference Citation Analysis]
11 Donnelly MC, Stableforth W, Krag A, Reuben A. The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary. Gastroenterology 2022:S0016-5085(22)00149-4. [PMID: 35331440 DOI: 10.1053/j.gastro.2022.02.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lazarus JV, Mark HE, Rinella ME, Colombo M. Editorial: global liver fat accumulation and global health—towards a sustainable development goal. Authors' reply. Aliment Pharmacol Ther 2022;55:489-90. [DOI: 10.1111/apt.16768] [Reference Citation Analysis]